Cytosorbents Corporation

NasdaqCM:CTSO Stock Report

Market Cap: US$43.5m

Cytosorbents Balance Sheet Health

Financial Health criteria checks 4/6

Cytosorbents has a total shareholder equity of $23.3M and total debt of $5.0M, which brings its debt-to-equity ratio to 21.7%. Its total assets and total liabilities are $53.3M and $30.0M respectively.

Key information

21.7%

Debt to equity ratio

US$5.04m

Debt

Interest coverage ration/a
CashUS$14.13m
EquityUS$23.28m
Total liabilitiesUS$29.99m
Total assetsUS$53.26m

Recent financial health updates

Recent updates

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Mar 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Jan 06
Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Nov 10
Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Jul 13
Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

May 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Mar 08
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents secures $4.3M contract by U.S. Department of Defense

Oct 06

CytoSorbents stock rises on US DoD contract to develop device for universal plasma

Sep 09

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Sep 02
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents gets reimbursement for CytoSorb in Turkey

Aug 23

CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system

Aug 17

Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M

Aug 02

We're Not Very Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Mar 03
We're Not Very Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: CTSO's short term assets ($25.7M) exceed its short term liabilities ($14.5M).

Long Term Liabilities: CTSO's short term assets ($25.7M) exceed its long term liabilities ($15.4M).


Debt to Equity History and Analysis

Debt Level: CTSO has more cash than its total debt.

Reducing Debt: CTSO's debt to equity ratio has reduced from 58.7% to 21.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CTSO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CTSO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.3% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.